Stockreport

Clovis Oncology Announces 2019 Operating Results

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
PDF Rubraca® (rucaparib) net product revenue totaled $143.0M for 2019 and $39.3M for Q4 2019Net product revenue for 2019 up 50% over 2018 46% reduction in net cash utilized [Read more]